Advertisement
Advertisement

BBNX

BBNX logo

Beta Bionics, Inc. Common Stock

14.39
USD
Sponsored
+0.52
+3.75%
Jun 09, 16:00 UTC -4
Closed
exchange

After-Market

14.50

+0.11
+0.76%

BBNX Earnings Reports

Positive Surprise Ratio

BBNX beat 4 of 6 last estimates.

67%

Next Report

Date of Next Report
Jul 27, 2026
Estimate for Q2 26 (Revenue/ EPS)
$32.18M
/
-$0.60
Implied change from Q1 26 (Revenue/ EPS)
+16.48%
/
+22.45%
Implied change from Q2 25 (Revenue/ EPS)
+38.48%
/
+53.85%

Beta Bionics, Inc. Common Stock earnings per share and revenue

On Apr 21, 2026, BBNX reported earnings of -0.49 USD per share (EPS) for Q1 26, beating the estimate of -0.49 USD, resulting in a 1.69% surprise. Revenue reached 27.63 million, compared to an expected 27.50 million, with a 0.44% difference. The market reacted with a -0.57% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of -0.60 USD, with revenue projected to reach 32.18 million USD, implying an increase of 22.45% EPS, and increase of 16.48% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Mesa Laboratories Inc
Report Date
May 27, 2026 For Q4 26
Estimate
$0.34
Actual
-$0.75
Surprise
-316.26%
logo
Autonomix Medical, Inc. Common Stock
Report Date
May 27, 2026 For Q4 26
Estimate
-$0.26
Actual
-$0.23
Surprise
+13.27%
FAQ
For Q1 2026, Beta Bionics, Inc. Common Stock reported EPS of -$0.49, beating estimates by 1.69%, and revenue of $27.63M, 0.44% above expectations.
The stock price moved down -0.57%, changed from $12.27 before the earnings release to $12.20 the day after.
The next earning report is scheduled for Jul 27, 2026.
Based on -- analysts, Beta Bionics, Inc. Common Stock is expected to report EPS of -$0.60 and revenue of $32.18M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement